
Transplant Hepatology @MCW | @Uconnim & @UNMC Alumni || MBA @Frankfurtschool ๐ || Trilingual ๐ช๐ฌ ๐บ๐ธ ๐ช๐ธ || ๐พ โฝ๏ธ || ๐งโ๐งโ๐ง ||
Joined August 2011
- Tweets264
- Following312
- Followers1.4K
- Likes944
Pinned Tweet
๐ข๐ช๐ฌ First-Ever Data on Egyptian Matched Applicants ๐บ๐ธ๐
Out of 111 matched applicants:
๐น 92 participated in the statistics
๐ธ 53 are featured in the Match Highlights PDF (headshots + hospitals)
๐ฉโโ๏ธ 25 females vs. ๐จโโ๏ธ 67 males
๐ฅ Ain Shams University led with 27 matches
๐ See comments for the full stats & Match Highlights PDF! ๐
๐ฏ To support future applicants, we launched a free mentorship program!
๐ค Each upcoming applicant will be paired with a mentor
๐ Mentors will guide, review applications & share valuable insights
๐ Are you a mentor or an upcoming applicant?
๐ Register using the links below!
Letโs lift each other up and grow our communityโs impact in U.S. residency programs ๐ช๐ฌโจ๐บ๐ธ
โ ๏ธ Disclaimer: All data were submitted by matched residents themselves. This does not include all matched Egyptian applicants, but represents those who voluntarily participated.
Congratulations to all the incredible Egyptian doctors who matched this year! ๐ Huge thanks to the amazing team behind this project โ Mark and Mazen โ for their dedication and hard work! ๐ช๐ฌ๐
@M_S_ANEES @Dr_MazenIbrahem
๐ New AGA/AASLD PBC (Primary Biliary Cholangitis) guideline: 6 recommendations, only 1 strong. My clinic takeaways:
AMA-negative? Check sp100/gp210 before biopsyโnegative results donโt exclude PBC.
Start UDCA 13โ15 mg/kg/day at diagnosis. Continue even with partial responseโthe only strong recommendation.
๐ฏ Aim for ALP normalization, not just improvement. Assess ALP + bilirubin at 6โ12 months; at 6 months if high risk (LSM โฅ10 kPa or age <62).
Inadequate response? Add elafibranor or seladelpar; monotherapy if UDCA-intolerant. Clinical outcome data remain pending.
Moderateโsevere itch? Consider linerixibat through shared decision-making: modest benefit, diarrhea trade-off.
After transplant? Start UDCA early to reduce recurrence and graft loss.
Bottom line: assess risk early, aim for biochemical remission, and act on inadequate response.
๐ gastrojournal.org/article/S0โฆ
#livertwitter
6
344
The Baveno VIII is now online!
Itโs finally hereโผ๏ธ
๐ Baveno VIII has arrived โ just in time for some good summer reading โ๏ธ๐
Time to dive into the latest consensus on portal hypertension from @BavenoCoop
Enjoy! ๐
๐ journal-of-hepatology.eu/artโฆ
4
726
Ismail Elkhattib retweeted
๐ Our ERAS Masterclass is LIVE! ๐ช๐ฌ๐บ๐ธ๐ฉบ
โHow to Master the ERAS Applicationโ practical tips, common mistakes & strategies from Egyptian physicians training in the US.
๐๏ธ Ahmed Elhatw, Ismail Elkhattib, Mohamed Aly & Mohamed Awad
๐ค Shady Elrashidy
๐ฅ youtu.be/gqBu5GTnMKA
Ismail Elkhattib retweeted
๐ซ EMG presents: Mastering ERAS โ one full session on cracking the residency application, hosted by Egyptian Pharaohs now in Peds GI, Surgery, Transplant Hep, IM & Psychiatry.
๐
Sun, July 26 ยท 9am ET / 4pm Cairo.
Stay Tuned!
#EgyptianMatch #Match2027
Ismail Elkhattib retweeted
๐ From #DDW2026 Poster to Full Paper!
Excited to share our latest systematic review and meta-analysis:
Pre-Emptive TIPS Versus Standard Care for Patients With Cirrhosis and Variceal Bleeding
๐ 6 randomized controlled trials | 424 patients
Our analysis found that pre-emptive TIPS (within 24โ72 hours) significantly:
โ
Reduced variceal rebleeding
โ
Lowered the risk of new/worsening ascites
โ
Decreased spontaneous bacterial peritonitis
โ
Reduced hepatorenal syndrome
โ
Improved the composite outcome of rebleeding or death
Although overall survival did not reach statistical significance, these results further support the role of early TIPS (within 24โ72 hours) in improving important clinical outcomes among high-risk patients with acute variceal bleeding.
I'm grateful to all my co-authors and collaborators for their dedication throughout this project. It is rewarding to see this research progress from a DDW poster presentation to a published manuscript. @IKhattib @MT_abuelazm
๐ Read the full paper: sciencedirect.com/science/arโฆ
#DDW #Gastroenterology #Hepatology #Cirrhosis #PortalHypertension #VaricealBleeding #TIPS #LiverDisease #MetaAnalysis #EvidenceBasedMedicine #GIResearch #MedTwitter #GITwitter
Ismail Elkhattib retweeted
๐ From #DDW Poster to Full Paper!
Excited to share our publication:
Vagal Nerve Stimulation for Chronic Constipation: A Systematic Review & Meta-analysis of Randomized Controlled Trials
๐ 6 RCTs | 356 participants
Our meta-analysis found that vagus nerve stimulation significantly improved:
โ
Weekly spontaneous bowel movements (SBM)
โ
Complete spontaneous bowel movements (CSBM)
โ
Stool consistency (BSFS)
โ
Abdominal pain (VAS)
โ
IBS Symptom Severity Score (IBS-SSS)
These findings support the growing role of non-invasive vagal neuromodulation as a promising treatment for chronic constipation while highlighting the need for larger, high-quality randomized trials.
๐ Read the paper: sciencedirect.com/science/arโฆ
Grateful for collaboration with rest of my colleagues on this paper @IKhattib @MT_abuelazm
#DDW #Gastroenterology #GI #Neurogastroenterology #NeuroGI #Constipation #IBS #VagusNerve #Neuromodulation #MetaAnalysis #EvidenceBasedMedicine #MedTwitter #GITwitter #DigestiveHealth
What a year! Grateful for the knowledge gained, the mentors who guided me, the patients who taught me, and the experiences that shaped me. Transplant Hepatology fellowship wrapping up soon โ
๐๐๐๐
@AltorkNade21396 @UNMC_GIHEP
๐โจ Summary of the newest evidence-based updates featured by the Liver Fellow Network ๐๐งฌ
๐ค Can less be more?
NAC is the cornerstone of acetaminophen toxicity treatment but can shorter regimens offer similar protection with better tolerability?
โจ Review the latest evidence
๐ฉบ Explore practical clinical implications
๐ Key takeaways for clinicians
By: @IKhattib
2
509
ูุงู ๏ทบ:
โุฃุญุจูู ุงููุงุณู ุฅูู ุงูููู ุฃููุนููู
ูููุงุณ"
๐ช๐ฌ Attention Egyptian IMGs applying to Match 2027!
EMGโs Mentee Applications are NOW OPEN.
Last year we had 50+ mentors and 200+ mentees. This year weโre coming in stronger with 100+ mentors ready to guide you through the U.S. residency journey.
Apply now: shorturl.at/0XtPl
We would be honored to have you join our mentorship program and help inspire and support the next generation
From Egyptian lecture halls to US residency programs ๐ช๐ฌโจ
Now itโs our turn to help the next batch get there too.
Free mentorship by Egyptian mentors for Egyptian mentees.
Matched this year and want to give back? Fill the mentor form ๐
forms.gle/B8iYi2Ca9Vz3DPz57
Ismail Elkhattib retweeted
Thrilled and honored to receive the Poster of Distinction Award at #DDW2026! ๐
Our study highlights that cholangiocarcinoma mortality in the U.S. is rising at an accelerating rate especially since 2007 while end-of-life care has increasingly shifted toward home and hospice settings over the past two decades, with a recent slight decline.
These findings emphasize critical gaps in prevention, treatment, and equitable access to quality end-of-life care, particularly for vulnerable populations.
Grateful to my collaborators who made this work possible!
@AhmedAwahedMD @IKhattib
#DDW2026 #DigestiveDiseaseWeek #Cholangiocarcinoma #GIOncology #CancerResearch #HealthEquity #EndOfLifeCare #MedicalResearch #Hepatology #Oncology @AGA_Gastro @AmerGastroAssn
Proud of my Egyptian colleagues, for the second year in a row we are able to gather some data about the matched applicants!
Stay tuned for more!!!
Ismail Elkhattib retweeted
Missed #BavenoVIII and feeling some regret? No worriesโฆ
This Wednesday, a new episode of Talk Liver to Me drops
๐๏ธ@tom_marjot, @MattiasMandorf1 & Cristina Ripoll unpack the key takeaways from #BavenoVIII
๐ easl.eu/event/baveno-viii-taโฆ
#LiverTwitter #LiverX
Ismail Elkhattib retweeted
As the role of #GLP1 therapies in #MASLD continues to grow, clinicians need clear guidance.
A new Practice Guidance update in @HEP_Journal provides evidence-based recommendations on using semaglutide therapy for MASH, including patient selection, comorbidity management, and monitoring strategies.
๐ View the update: bit.ly/4s4QM6A
๐ First meta-analysis on recompensation in decompensated cirrhosis
๐ More common in viral etiologies & lower MELD
๐ Linked to lower risk of HCC & death
โ
A meaningful clinical endpoint
Read more here: ow.ly/2qx150YvNUk
#LiverTwitter @wong__yujun @BavenoCoop
Ismail Elkhattib retweeted
New @AmerGastroAssn MASLD pathway: for people with type 2 diabetes, you can now skip FIB-4 and go straight to elastography when itโs available.
gastrojournal.org/article/S0โฆ
๐ค What if endoscopy sedation could be safer without tradeoffs?
Our RCT analysis shows esketamine reduces hypotension & hypoxemia, with no recovery penalty ๐โจ
So proud of this team and grateful for the opportunity to serve as senior author on this project. ๐
๐ link : link.springer.com/article/10โฆ
#GI #Anesthesia #MedTwitter
7
1,098
๐จ New study alert!
Excited to share our latest research: In a nationwide TriNetX cohort of 176K+ patients with Barrettโs esophagus, combining aspirin with PPI therapy was linked to a lower risk of esophageal cancer vs PPI alone (ORโฏ0.799,โฏ95%โฏCIโฏ0.679โ0.941). ๐ง ๐
Both low and high doses showed benefit. Is it time to add aspirin to the Barrettโs treatment regimen? ๐ค
Grateful for the mentorship of @ElfertKhaled & Dr. Rezaizadeh on this project. And grateful for the hard work of my amazing co-authors @MelnaggarM @AmeerAwashra @MT_abuelazm
#GI #BarrettsEsophagus #Research #EvidenceBasedMedicine
tandfonline.com/eprint/TKNCKโฆ























